Biogen BIIB Balance Sheet Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $3.01B+26.7% | $2.38B+126% | $1.05B-69.3% | $3.42B+51.2% | ||
| $807.2M— | $0— | $0-100% | $1.47B-4.4% | ||
| $145.4M+54.8% | $93.9M+14.9% | $81.7M+287% | $21.1M— | ||
| $8.97B+20.3% | $7.46B+8.7% | $6.86B-29.9% | $9.79B+24.6% | ||
| $3.06B-4.0% | $3.18B-3.9% | $3.31B+0.3% | $3.3B-3.4% | ||
| $6.49B+0.2% | $6.48B+4.2% | $6.22B+8.2% | $5.75B-0.2% | ||
| $7.38B-23.9% | $9.69B+15.9% | $8.36B+368% | $1.79B+20.9% | ||
| $29.44B+5.0% | $28.05B+4.5% | $26.84B+9.3% | $24.55B+2.8% | ||
| $432M+1.8% | $424.2M+5.2% | $403.3M-17.9% | $491.5M-16.6% | ||
| $3.35B-39.4% | $5.53B+61.0% | $3.43B+4.9% | $3.27B-23.9% | ||
| $6.29B+38.3% | $4.55B-33.0% | $6.79B+8.1% | $6.28B+0.1% | ||
| $305.3M-97.3% | $11.33B-5.9% | $12.05B+7.9% | $11.17B-13.6% | ||
| $100K0.0% | $100K0.0% | $100K0.0% | $100K-100.0% | ||
| $20.55B+6.7% | $19.26B+9.3% | $17.63B+7.1% | $16.47B+18.4% | ||
| $18.26B+9.2% | $16.72B+13.0% | $14.8B+10.5% | $13.4B+23.0% | ||
| $29.44B+5.0% | $28.05B+4.5% | $26.84B+9.3% | $24.55B+2.8% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Biogen's total assets?
- Biogen (BIIB) holds $29.5B in total assets, up 5.2% year over year.
- How much debt does Biogen have?
- Biogen carries $6.6B in total debt against $18.7B of shareholders' equity, a debt-to-equity ratio of 0.35.
- How much cash does Biogen have?
- Biogen holds $3.4B in cash and equivalents.
- Can Biogen cover its short-term obligations?
- Its current ratio is 3.06 — current assets exceed current liabilities.
- Where does Biogen's balance sheet data come from?
- Every line is extracted from Biogen's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
